55 Followers SGX:P8A - Cordlife (SGD 0.41) CORDLIFE GROUP LIMITED
Sector: Health Services, Industry: Medical/Nursing Services

SGD 0.41    +0.0 (+0%)
Show Basic Chart | 3M    6M    1Y    3Y    5Y          

21 Feb 2020


21 Feb 2020

52 Wk Range: 0.385 - 0.625

Day's Range: 0.41 - 0.41

Last Volume: 0

Current Yield: 0.98%

Projected Yield: 0.98%

Future Yield: [Friends Only]

Dividend Strength: [Friends Only]

21 Feb 2020

Metric P8A S.Median
Beta 0.58 0.22
VaR 31.52 29.53
E.Shortfall 42.32 36.9
Liquidity 5,688.88 19.69K


21 Feb 2020

PE: 17.9

Market Cap: 104M

Price Over Book: 0.819

Price Over Sales: 1.03

Return On Assets: 2.7%

Return On Equity: 4.7%

NAV Over Price: [Friends Only]


CEO: Poh Lan Tan, MBA

Founded Year: 2001

Headquarters: Singapore

Shares Outstanding: 253.7M

Security Type: Stock

Useful Links
Investor Relations


Cordlife Group Ltd. is an investment holding company, which engages in the provision of cord blood banking services. It operates through the Banking and Diagnostics segments. The Banking segment comprises of cord blood, and cord lining and tissue services, which collects, processes and stores in laboratories. The Diagnostics segment consists of Metascreen, which is anon-invasive metabolic screening test designed for newborn babies, non-invasive prenatal testing and eyescreen, and a paediatric vision-screening services. The company was founded on May 2, 2001 and is headquartered in Singapore.